Healint collects the data of a phase II double blind cross-over fully virtual clinical trial to assess the efficacy of a new treatment for migraine sufferers. The first of its kind.
Read More
According to the CEO of Google Cloud, technology has the potential for tremendous impact in healthcare in three areas.
Read More
The “COmbining UbRogepAnt and Preventives for MiGrainE” (COURAGE) study used Healint’s platform to collect real-world data
Read More
Healint’s offer for virtual clinical trials now includes Aural Analytics A2E technology of speech analysis to assess brain health, that can be used as an endpoint to evaluate the efficacy of a new treatment.
Read More
Migraine Buddy and Speak your Migraine Philippines are all about community and giving support and advice to those who are saying enough is enough.
Read More
NHS organisations in around 50% of NHS regions offer libraries on ORCHA. We are very proud to join the ORCHA library and win from start the best scoring in migraine category.
Read More
Amid growing concerns about the impact of the novel coronavirus (COVID-19) worldwide, it’s important to both understand the impact and address specific considerations for people living with migraine.
We have asked our wide Migraine Buddy community on how COVID-19 impacts them. Check-out the results in this article.
In our previous blog, we shared an observational study on Migraine Buddy within the US territory. As the situation is evolving and more cases were declared around the world, check out a comparative analysis from January 2020 up to today. Impressive!
Read More
With the COVID-19 affecting population worldwide, the fear of being contaminated is generating additional stress in all of us. As a cause, we see an increase in stress-related migraines within the population of Migraine Buddy users too.
Read More